Feb 7 (Reuters) - Pcas SA PCAS.PA :
* PCAS GROUP HAS GENERATED CONSOLIDATED NET SALES OF EUR
226.4
MILLION AS OF DECEMBER 31, 2022
* LEVEL OF ACTIVITY REMAINS INSUFFICIENT TO COVER FIXED
COSTS AT
SEVERAL PHARMACEUTICAL SYNTHESIS SITES, AND DUE TO INVENTORY
DEPRECIATIONS FOR OUT-OF-SPECIFICATION PRODUCTS
* PCAS HAS TO STUDY A TEMPORARY REDUCTION IN ACTIVITY ON
PRODUCTION SITE CONCERNED BY SUCH PRODUCT, INCLUDING SOME
WORKSHOPS DEDICATED TO PRODUCTION OF ESTETROL
* RETURN TO POSITIVE RESULTS ANNOUNCED FOR 2023 WILL BE
DELAYED
* WILL CONTINUE TO BENEFIT FROM SUPPORT OF ITS MAJORITY
SHAREHOLDER SEQENS (OWNING 76.66%) FOR FINANCING OF ITS
ACTIVITIES AND ITS DEVELOPMENT.
Source text for Eikon: ID:nGNE8xGJFH
Further company coverage: PCAS.PA
(Reporting by Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com))